In its fourth major biopharma deal since its 2019 founding, Repertoire Immune Medicines signed a partnership with Eli Lilly and Co. to develop tolerizing therapies for several autoimmune diseases, ...
Learn how bilateral extended reporting in claims-made insurance extends your ability to report claims and secures protection after policy changes or cancellations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results